Moderna, Excision each enter HIV battle with mRNA and CRISPR tech - FierceBiotech
Moderna and Excision BioTherapeutics are stepping into a battle with HIV, a 41-year epidemic that has confuddled drug developers and vaccine makers the world over. The famed vaccine marker will use its mRNA tech, while Excision will try and tackle the virus w…
Moderna and Excision BioTherapeutics are stepping into a battle with HIV, a 41-year epidemic that has confuddled drug developers and vaccine makers the world over.
The COVID-19 vaccine maker has sta… [+3512 chars]
Read More
Other Stories in Health
- Father's gut health in mice linked to offspring's well-being, study finds
- SGEM Twitter Poll #438
- 2024 Applications to University of British Columbia (UBC) Nurse Practitioner Masters Program
- New drug candidate reverses obesity in mice by transforming liver metabolism
- Kaiser SoCal New Grad July 2024
- How to Comfort the Grieving Without Saying "Sorry for Your Loss"
- Mississippi lawmakers expected to vote on Medicaid expansion plan with work requirement
- Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms
- Food additive emulsifiers linked to increased risk of type 2 diabetes
.png)
